China Jo-Jo Drugstores In... (CJJD)
undefined
undefined%
At close: undefined
1.82
0.00%
After-hours Jan 03, 2025, 01:27 PM EST

Company Description

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China.

The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming.

Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items.

The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours.

In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms.

Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM.

As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores.

The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

China Jo-Jo Drugstores Inc.
China Jo-Jo Drugstores Inc. logo
Country CN
IPO Date Oct 1, 2009
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 939
CEO Lei Liu M.D.

Contact Details

Address:
Hai Wai Hai Tongxin Mansion
Hangzhou,
CN
Website https://www.jiuzhou-drugstore.com

Stock Details

Ticker Symbol CJJD
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001856084
CUSIP Number 16949A206
ISIN Number KYG2124G1120
Employer ID 00-0000000
SIC Code 5912

Key Executives

Name Position
Lei Liu M.D. Chairman & Chief Executive Officer
Ming Zhao Chief Financial Officer
Steve Liu Investor Relations Director
Yan Liu Secretary

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13D/A [Amend] Filing
Nov 12, 2024 6-K Filing
Oct 21, 2024 6-K Filing
Sep 03, 2024 SC 13D/A [Amend] Filing
Jul 30, 2024 20-F Filing
Jul 30, 2024 6-K Filing
Jun 11, 2024 424B5 Filing
Jun 11, 2024 6-K Filing
May 31, 2024 6-K Filing
May 10, 2024 424B5 Filing